Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CMPX-2023 in a psoriasis skin transplant model
NL-OMON38996Active, not recruiting
- Sponsor
- Complix
- Start
- Jun 2013
- Modality
- Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of CMPX-2023 in psoriasis and plaque psoriasis, sponsored by Complix. Started Jun 2013; status: active, not recruiting.
02
Drugs
CMPX-2023
03
Conditions
psoriasisplaque psoriasis
Beyond the preview
Go deeper on NL-OMON38996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38996.